The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | 20,500 | 1,408,901 | SH | SOLE | 1,408,901 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 9,988 | 610,523 | SH | SOLE | 610,523 | 0 | 0 | ||
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,813 | 5,347,689 | SH | SOLE | 5,347,689 | 0 | 0 | ||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 28,803 | 1,023,214 | SH | SOLE | 1,023,214 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 22,260 | 3,601,926 | SH | SOLE | 3,601,926 | 0 | 0 | ||
| APTINYX INC | COM | 03836N103 | 3,273 | 8,891,758 | SH | SOLE | 8,891,758 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 57,330 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| ARYA SCIENCES ACQUISITN CORP | CLASS A ORD SHS | G31658100 | 4,905 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 14,143 | 2,485,638 | SH | SOLE | 2,485,638 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,885 | 487,500 | SH | SOLE | 487,500 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 14,402 | 1,642,210 | SH | SOLE | 1,642,210 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 24,780 | 2,647,473 | SH | SOLE | 2,647,473 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 45,281 | 2,305,558 | SH | SOLE | 2,305,558 | 0 | 0 | ||
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 56,533 | 5,415,000 | SH | SOLE | 5,415,000 | 0 | 0 | ||
| EQRX INC | COM | 26886C107 | 49,518 | 10,003,573 | SH | SOLE | 10,003,573 | 0 | 0 | ||
| FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 3,045 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| INVIVYD INC | COM | 00534A102 | 6,063 | 1,937,207 | SH | SOLE | 1,937,207 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 9,517 | 1,431,058 | SH | SOLE | 1,431,058 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 58,566 | 8,663,673 | SH | SOLE | 8,663,673 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 4,240 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 23,752 | 1,822,883 | SH | SOLE | 1,822,883 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | 66,641 | 3,428,014 | SH | SOLE | 3,428,014 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | 24,395 | 3,180,601 | SH | SOLE | 3,180,601 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 19,057 | 2,260,572 | SH | SOLE | 2,260,572 | 0 | 0 | ||
| RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 27,244 | 8,434,560 | SH | SOLE | 8,434,560 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 18,015 | 11,622,598 | SH | SOLE | 11,622,598 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E105 | 3,700 | 7,929,918 | SH | SOLE | 7,929,918 | 0 | 0 | ||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 137,837 | 4,831,307 | SH | SOLE | 4,831,307 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 6,971 | 1,082,404 | SH | SOLE | 1,082,404 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 6,957 | 1,921,790 | SH | SOLE | 1,921,790 | 0 | 0 | ||
| THIRD HARMONIC BIO INC | COM | 88427A107 | 43,253 | 2,280,082 | SH | SOLE | 2,280,082 | 0 | 0 | ||
| X4 PHARMACEUTICALS INC | COM | 98420X103 | 10,926 | 6,389,436 | SH | SOLE | 6,389,436 | 0 | 0 | ||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 8,164 | 2,805,413 | SH | SOLE | 2,805,413 | 0 | 0 | ||